Previous Close | 0.0150 |
Open | 0.0000 |
Bid | 0.0150 x 0 |
Ask | 0.0350 x 0 |
Day's Range | 0.0150 - 0.0150 |
52 Week Range | 0.0100 - 0.0650 |
Volume | |
Avg. Volume | 9,732 |
Market Cap | 440,623 |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, is pleased to announce it has entered into an exclusive licensing agreement with PA Options for Wellness Inc. ("PA Options") for Pennsylvania. PA Options, founded in 2014, has six dispensaries doing business as Vytal Options. Ovation's products (co-branded as Invibe® MD and Vytal Options) will
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, announces it has signed a Supply and Distribution Agreement with Golfer's CBD Ltd., an international CBD brand focused on the health and wellness of golfers around the world. The Agreement covers the rights in the golf market for the United States, the United Kingdom and Europe.
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, today announced it will be participating and be taking new licensee meetings at the MJ Unpacked conference being held at the MGM Hotel in Las Vegas from September 28 to 30th, 2022. Ovation will participate as an exhibitor (Booth 218) and management will be available for one-on-one meetings throughout t
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted Ovation a patent entitled "Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC)"; (US Patent Number: 11,439,602), with an expiry of February 2041.
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company") a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce it has entered into an exclusive licensing agreement for its cannabis formulations for the states of Oklahoma, Missouri, New Mexico and Mississippi with Stash House Distribution ("Stash House"). Stash House is a leading national cannabis manufacturing, sales, and logistics company